Article Details

Septerna doses first subjects in Phase I hypoparathyroidism treatment trial

Retrieved on: 2024-09-30 17:43:43

Tags for this article:

Click the tags to see associated articles and topics

Septerna doses first subjects in Phase I hypoparathyroidism treatment trial. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. The trial is designed to assess the safety, tolerability, pharmacokinetics (PK), and ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo